BioPharma Management and Consulting SRL
BioPharma Management and Consulting reported total assets of €3.16m at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jun 2026).
By total assets for 2025, BioPharma Management and Consulting ranks among the 1,000 largest of the 8,148 companies in its sector (NACE 8299) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of BioPharma Management and Consulting shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -9 % Total assets +918 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
BioPharma Management and Consulting's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 28 Feb 2025
- Year ended 31 Dec 2023filed on 04 Oct 2024
- Year ended 31 Dec 2022filed on 29 Mar 2023
- Year ended 31 Dec 2021filed on 26 May 2022
BioPharma Management and Consulting's financial analysis
- Solvency0.6%sector median: 47.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of BioPharma Management and Consulting
1 active director(s) in the register.
BioPharma Management and Consulting's shareholders and holdings →BioPharma Management and Consulting's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0664.691.906
- VAT number
- BE0664691906
- Peppol
- Registered · 0208:0664691906 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Oct 2016
- Registered office
- 5650 Walcourt
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
BioPharma Management and Consulting (SRL) has been based in Walcourt since 2016, active in: other business support service activities n.e.c.. For 2025, it reports a net profit of 29,020 € and equity of 18,600 €; its revenue is not published. Its solvency stands at 0.6%, below the median of its sector (47.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to BioPharma Management and Consulting
Companies in the same business, of comparable size and area, outside its group.
- Blue Builders Other business support service activities n.e.c. Beringen · balance sheet €1.18m
- Finmore Other business support service activities n.e.c. Schilde · balance sheet €3.13m
- Westlimco Other business support service activities n.e.c. Brussels · balance sheet €3.36m
- Iovis Other business support service activities n.e.c. Deerlijk · balance sheet €2.90m
- Hertimo Other business support service activities n.e.c. Heist-op-den-Berg · balance sheet €2.79m
- Dejora Other business support service activities n.e.c. Antwerp · balance sheet €2.76m
- Belco Business Center and Facilities Other business support service activities n.e.c. Forest · balance sheet €3.70m
- Provesta Other business support service activities n.e.c. Meise · balance sheet €2.47m
Frequently asked questions about BioPharma Management and Consulting
What is the revenue of BioPharma Management and Consulting?
BioPharma Management and Consulting files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of BioPharma Management and Consulting?
In Belgium, the VAT number is the company number prefixed with BE: BE0664691906 for BioPharma Management and Consulting, if the company is VAT-registered. Its company number (CBE) is 0664.691.906.
Where is the registered office of BioPharma Management and Consulting?
According to the CBE register, the registered office of BioPharma Management and Consulting is in 5650 Walcourt.
What is the equity of BioPharma Management and Consulting?
At the close of the 2025 financial year, the equity of BioPharma Management and Consulting amounts to 18,600 €, a solvency of 0.6% of total assets.
Who manages BioPharma Management and Consulting?
The register lists 1 active mandates at BioPharma Management and Consulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is BioPharma Management and Consulting within its sector?
By total assets for 2025, BioPharma Management and Consulting ranks among the 1,000 largest of the 8,148 companies in its sector (NACE 8299) in Belgium that filed accounts for that financial year.
The full file of BioPharma Management and Consulting
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →